ZIM Laboratories Limited (BSE: 541400)
Health Care · Pharmaceuticals · IN
Rs125.05
+14.10% today · +63.6% 1Y
ZIM Laboratories Limited (BSE: 541400) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $69.99M.
Over the last twelve months the share price has gained 63.6%, trading between 59.72 and 133.95.
Tweenvest scores ZIM Laboratories Limited across four factors: quality 65/100, value 35/100, growth 19/100. Its strongest factor is quality.
541400 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $69.99M
- Revenue (TTM)
- $41.97M
- P/E
- 169.71
- EPS
- 0.74
- Dividend yield
- —
- Beta (5Y)
- 0.82
- 52-week high
- Rs133.95
- 52-week low
- Rs59.72
- Avg volume (3M)
- —
- Shares outstanding
- 53.55M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,234.00 | +0.03% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.18 | +0.01% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.90 | -0.35% |
| Roche Holding AGSWX: ROP | $371.62B | CHF370.90 | -0.78% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.18 | -1.27% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.50 | -0.25% |
Figures last refreshed Aug 18, 2026.